How can we prevent diarrhea induced by systemic treatments in oncological patients? An evaluation of phase II trials.

IF 2.7 3区医学 Q2 PHARMACOLOGY & PHARMACY

Expert Opinion on Emerging Drugs Pub Date : 2023-12-01 Epub Date: 2023-12-26 DOI:10.1080/14728214.2023.2264182

Andrea Esposito, Paolo Bossi

引用次数: 0

查看原文本刊更多论文

如何预防肿瘤患者因全身治疗引起的腹泻？对第二阶段试验的评估。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Expert Opinion on Emerging Drugs 医学-药学

CiteScore

5.90

自引率

0.00%

发文量

审稿时长

>12 weeks

期刊介绍： Expert Opinion on Emerging Drugs (ISSN 1472-8214 [print], 1744-7623 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing structured reviews on Phase II and Phase III drugs/drug classes emerging onto the market across all therapy areas, providing expert opinion on their potential impact on the current management of specific diseases.